Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Efficient electroporation of peptides into adherent cells: investigation of the role of mechano-growth factor in chondrocyte culture.

Schönenberger C, Schütz A, Franco-Obregón A, Zenobi-Wong M

Biotechnology letters5 Jan 2011Cited by 8 (Europe PMC)

PMID21207114 (opens in a new tab)DOI10.1007/s10529-010-0508-1 (opens in a new tab)PepBankPUB-21207114
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking MGF / PEG-MGF.

  1. 01LabNot a test of MGF / PEG-MGF aloneIn vitro (cells)Other

    Under optimal conditions, in situ electroporation delivered a model peptide (MGF) into adherent primary chondrocytes with an efficiency of close to 50%.

    In plain wordsIn cells, electric pulses moved the MGF peptide into about half of the cartilage cells under the best conditions.

    Peptide
    MGF / PEG-MGF
    Outcome
    Not applicableElectroporation efficiency of FITC-labeled MGF into chondrocytes
    Study

    n: not reported in source

    Adherent primary chondrocytes
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    Electroporation efficiency
    ≈ 50%
    optimal conditions

    Source sentences

    Summary
    Under optimal conditions, an electroporation efficiency of close to 50% could be achieved.
    1 context sentence
    Summary · context
    FITC-labeled MGF was added to cultures of adherent primary chondrocytes grown on ITO coated glass slides.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.